16 Participants Needed

Enlicitide + Lithium for Healthy Subjects

Age: 18 - 65
Sex: Any
Trial Phase: Phase 1
Sponsor: Merck Sharp & Dohme LLC
Must be taking: Lithium
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Researchers have designed a new study medicine called enlicitide decanoate (MK-0616) as a new way to lower the amount of low-density lipoprotein cholesterol (LDL-C) in a person's blood. Enlicitide decanoate will be called "enlicitide" from this point forward. Lithium (also called lithium carbonate) is a medicine used in bipolar disorder.Researchers want to learn about lithium when taken at the same time with enlicitide.They want to:* Measure a person's blood to find out if the amount of lithium in the blood is the same when lithium is taken alone or with enlicitide* Learn about the safety of lithium when taken alone or with enlicitide and if people tolerate it

Research Team

MD

Medical Director

Principal Investigator

Merck Sharp & Dohme LLC

Eligibility Criteria

This trial is for healthy adults with no significant medical history, who haven't smoked or used nicotine/tobacco products in the last 3 months. It's designed to see how a new cholesterol-lowering medicine, enlicitide, interacts with lithium.

Inclusion Criteria

I haven't smoked or used nicotine products for at least 3 months.
I am generally healthy with no major medical issues.

Exclusion Criteria

I have a significant health or mental health condition.
I have had cancer in the past.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment Period 1

Participants receive a single oral dose of lithium carbonate

1 day
1 visit (in-person)

Treatment Period 2

Participants receive a single oral dose of lithium carbonate coadministered with enlicitide

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 weeks

Treatment Details

Interventions

  • Enlicitide
  • Lithium
Trial Overview The study is testing the effects of taking enlicitide and lithium carbonate together. Researchers will measure blood levels of lithium when taken alone versus alongside enlicitide to assess any differences and overall safety.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Lithium CarbonateExperimental Treatment1 Intervention
On Day 1 of Period 1, a single oral dose of lithium carbonate will be administered.
Group II: Enlicitide with Lithium CarbonateExperimental Treatment2 Interventions
On Day 1 of Period 2, a single oral dose of lithium carbonate will be coadministered with a single oral dose of enlicitide.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Merck Sharp & Dohme LLC

Lead Sponsor

Trials
4,096
Recruited
5,232,000+
Chirfi Guindo profile image

Chirfi Guindo

Merck Sharp & Dohme LLC

Chief Marketing Officer since 2022

Degree in Engineering from Ecole Centrale de Paris, MBA from New York University Stern School of Business

Robert M. Davis profile image

Robert M. Davis

Merck Sharp & Dohme LLC

Chief Executive Officer since 2021

JD from Northwestern University Pritzker School of Law, MBA from Northwestern University Kellogg Graduate School of Management, Bachelor's in Finance from Miami University

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security